Mirabella Financial Services’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Mirabella Financial Services’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,198	Closed	-$1.26M	–	711
2023 Q1	$1.26M	Buy	+5,198	New	+$598K	0.19%	106

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Mirabella Financial Services's RXDX Position: Q2 2023 in Review

Mirabella Financial Services sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 5,198 shares — an estimated $1.26M sold.

Mirabella Financial Services first reported a position in RXDX in Q1 2023 and held it in 1 quarter. The position peaked at $1.26M in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Mirabella Financial Services reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Mirabella Financial Services sold 5,198 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $1.26M.
Mirabella Financial Services first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Mirabella Financial Services's Prometheus Biosciences, Inc. Common Stock position peaked at $1.26M in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Mirabella Financial Services's 13F filing for Q2 2023, filed 7 Aug 2023.